MIRUM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.55 USD | -3.61% |
|
-0.81% | -16.84% |
| 10/05 | Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $53 From $57, Keeps Overweight Rating | MT |
| 08/05 | Transcript : Mirum Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | -3.61% | -0.81% | -16.84% | -11.94% | - | 120.05Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MIRM Stock
- Charts Mirum Pharmaceuticals, Inc.
- Comparison Chart
